Skip to main content
Login | Suomeksi | På svenska | In English

Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease

Show simple item record

dc.date.accessioned 2017-04-18T09:41:00Z
dc.date.available 2017-04-18T09:41:00Z
dc.date.issued 2017-04-18
dc.identifier.uri http://hdl.handle.net/123456789/11967
dc.title Clostridium Difficile Infection in Patients with Inflammatory Bowel Disease en
ethesis.discipline Gastroenterology en
ethesis.discipline Infectious Diseases en
ethesis.discipline Gastroenterologia fi
ethesis.discipline Infektiosairaudet fi
ethesis.discipline Gastroenterologi sv
ethesis.discipline Infektionssjukdomar sv
ethesis.discipline.URI http://data.hulib.helsinki.fi/id/610ea8bb-26cc-4fe1-92ce-d6ca513241e5
ethesis.discipline.URI http://data.hulib.helsinki.fi/id/E4f35b1b-77e4-4a29-8e23-0941bf68b7e5
ethesis.faculty Faculty of Medicine en
ethesis.faculty Medicinska fakulteten sv
ethesis.faculty Lääketieteellinen tiedekunta fi
ethesis.faculty.URI http://data.hulib.helsinki.fi/id/a4d5aaa2-b5aa-41a7-ba4c-e5e0df7a902d
ethesis.university.URI http://data.hulib.helsinki.fi/id/50ae46d8-7ba9-4821-877c-c994c78b0d97
ethesis.university Helsingfors universitet sv
ethesis.university University of Helsinki en
ethesis.university Helsingin yliopisto fi
dct.creator Vitikainen, Krista
dct.issued 2017
dct.language.ISO639-2 eng
dct.abstract Patients with inflammatory bowel disease (IBD) are at increased risk for developing symptomatic Clostridium difficile infection (CDI) with worse clinical outcomes, including mortality, as compared with the general population. IBD-patients are also more susceptible to have recurrences of CDI. At present, predisposing factors for CDI in IBD-patients are poorly established. To characterize IBD-related CDI, a retrospective cohort from HUS register was gathered. Patient characteristics were compared with two control groups: IBD-patients with CDI and CDI-patients. According to our results, there was no statistically significant difference in mortality rate between IBD- and CDI-patients in contrary to previous reports. We detected corticosteroid consumption in IBD patients with CDI to be greater than in patient with IBD alone. It could be considered as a risk factor for CDI. Clarifying risk factors for CDI could lead to better understanding of optimal treatment for CDI in IBD patients. en
dct.subject IBD
dct.subject CDI
dct.subject recurrenct infections en
dct.subject risk factors en
dct.language en
ethesis.language.URI http://data.hulib.helsinki.fi/id/languages/eng
ethesis.language English en
ethesis.language englanti fi
ethesis.language engelska sv
ethesis.supervisor Arkkila, Perttu
ethesis.thesistype pro gradu-avhandlingar sv
ethesis.thesistype pro gradu -tutkielmat fi
ethesis.thesistype master's thesis en
ethesis.thesistype.URI http://data.hulib.helsinki.fi/id/thesistypes/mastersthesis
dct.identifier.ethesis E-thesisID:b4e40b2e-9feb-45b5-a280-54c45b14e9ab
ethesis.degreeprogram Lääketieteen koulutusohjelma fi
ethesis.degreeprogram Medical curriculum en
ethesis.degreeprogram Medicinska utbildningsprogrammet sv
ethesis.degreeprogram.URI http://data.hulib.helsinki.fi/id/767842ad-05d0-4813-84df-c487f341f1ca
ethesis-internal.timestamp.reviewStep 2017-02-23 14:27:15:579
dct.identifier.urn URN:NBN:fi:hulib-201704183902
dc.type.dcmitype Text
dct.subject.mesh Tulehdukselliset suolistosairaudet fi
dct.subject.mesh Klostridi-infektiot fi

Files in this item

Files Size Format View
CDI IBD potilailla_Krista Vitikainen.pdf 906.1Kb PDF

This item appears in the following Collection(s)

Show simple item record